Genicular Artery Embolization Safe, Relieves Pain for Symptomatic Knee OA
Significant decrease seen in serum levels of vascular endothelial growth factor and interleukin-1 receptor antagonist at 12 months
AAP Offers Guidance for Tapering of Opioids to Prevent Withdrawal in Children
Signs and symptoms linked with withdrawal are relatively consistent in pediatric population; can be seen after five or more days of opioids
FDA Approves Ketamine Product, KETARx, for Surgical Pain Management
Drugmaker aims to pursue other applications in mental health, neurological, and pain disorders
FDA Approves Ajovy for Migraine Prevention in Children and Teens
Approval is for children and adolescents aged 6 to 17 years weighing ≥45 kg
Cognitive Functional Therapy Effective for Chronic Low Back Pain at Three Years
Cognitive functional therapy, with or without biofeedback, more effective than usual care for chronic disabling low back pain
FDA Requiring Stronger Safety Labels for Opioid Medications
Updated opioid safety labeling is based on new data from two large postmarketing observational studies
Perioperative Counseling Reduces Opioid Use After ACL Reconstruction Surgery
Authors say patients should be counseled to take opioids as a 'last resort' to manage pain, not to 'stay ahead of the pain'
Remote CBT-Based Therapy Yields Modest Improvements in Chronic Pain
Both telehealth and self-completed online intervention groups more likely to attain clinically important difference in pain severity versus usual care
Increase Seen in Reports of Lidocaine Poisonings and Mortality Since 2010
Following publication of advisories, reports of local anesthetic poisoning decreased, but reports of lidocaine poisoning and mortality increased
Fewer Opioids Being Prescribed for Low Back Pain in the Emergency Department
Opioids administered or prescribed in 35.0 and 32.5 percent of U.S. visits in 2016, respectively, compared with 24.5 and 13.5 percent in 2022
